OpenAI on Thursday announced the acquisition of Astral, the developer of open source Python tools that include uv, Ruff and ty. It says that it plans to integrate them with Codex, its AI coding agent ...

Researchers have found a metabolite in Burmese pythons that suppresses appetite in mice without some of GLP-1's side effects. And humans make it, too.

University of Colorado Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain ...

OpenAI, the leading artificial intelligence platform, has aimed to built a strong platform against Anthropic. The ChatGPT owner said on Thursday, March 20, 2026, it will acquire Python ...

By studying how snakes process large meals and long food breaks, scientists identified an overlooked compound in humans that could expand weight loss therapies.

OpenAI Group PBC today announced plans to acquire Astral Software Inc., a startup with a set of widely used Python development tools.  The terms of the deal were not disclosed. Astral’s development ...

Pythons eat huge meals after monthslong fasts. Researchers identified molecules that skyrocket in their blood after a meal. One caused obese mice to eat less and lose weight, similar to semaglutide.

OpenAI acquires Astral, the Python toolmaker, to enhance Codex AI coding assistant as it competes with Anthropic's Claude Code and Cursor.

What began in 1976 is still as strong as ever 50 years later. The Middle Keys marked five decades of showcasing one of Marathon’s foundational industries as the Original Marathon Seafood Festival ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

OpenAI said on Thursday it will acquire Python toolmaker Astral, as the ChatGPT ​owner looks to strengthen its portfolio ...

A molecule produced in abundance by pythons after big meals could lead the way to new weight loss drugs, a University of Colorado study says.